AGS:EURONEXT BRUSSELSageas SA/NV Analysis

Ageas is trading at €59.65, currently below its 20‑day (≈€61.59) and 50‑day (≈€60.86) moving averages but just above the 200‑day SMA (≈€59.02), suggesting a short‑term pull‑back within a longer‑term bullish trend. The RSI of 41.5 hints at mild oversold conditions, while a bearish MACD histogram reinforces caution on immediate upside. Support sits near €58.20 and resistance near €65.10, with volume trending upward and 30‑day volatility around 21%, indicating a relatively calm price environment. A low beta (~0.28) points to limited market‑wide risk, and the stock’s PE of 9.5 is well below the industry average of 16.4, making it appear cheap on earnings. The dividend yield of 5.87% and a payout ratio of 56% are supported by strong cash balances (€26.5 bn) and solid operating cash flow (€1.83 bn). Analysts project a median target of €66, implying roughly 10% upside, and the DCF fair value further underscores potential undervaluation. Fundamentally, revenue grew modestly 2.3% YoY, margins remain healthy (gross 30%, operating 10%, profit 13.4%) and ROE stands at 15%. Recent earnings commentary highlighted a FY25 net operating result of €1.655 bn, beating guidance and showing inflow growth of 9%. The balance sheet is comfortable despite a debt‑to‑equity of 79%, given the ample cash cushion. Overall, the combination of attractive valuation, robust dividend, and defensive insurance exposure supports a positive outlook across horizons.